当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析

亿帆医药

(002019)

  

流通市值:117.39亿  总市值:169.69亿
流通股本:8.41亿   总股本:12.16亿

亿帆医药(002019)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.38亿元,每股收益0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益858786.09万元,未分配利润462157.09万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1251088.78万元,负债392302.69万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入1,326,616,043.25,159,823,227.643,858,211,534.782,632,089,783.35
营业总成本1,200,723,203.714,758,180,864.673,531,892,029.962,363,162,281.95
营业利润157,061,740.52381,810,182.55383,633,544.49291,472,373.69
利润总额156,682,698.91388,656,952.28385,056,800.16293,650,644.56
净利润138,229,631.62323,621,712.62307,759,997.51212,445,979.23
其他综合收益20,675,101.78-25,329,608.54-10,825,241.37-17,359,424.85
综合收益总额158,904,733.4298,292,104.08296,934,756.14195,086,554.38
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计3,901,724,271.73,778,271,166.023,926,109,338.73,851,302,017.09
非流动资产合计8,609,163,489.228,507,516,922.738,443,649,535.018,285,386,580.39
资产总计12,510,887,760.9212,285,788,088.7512,369,758,873.7112,136,688,597.48
流动负债合计2,848,616,568.822,987,056,324.92,983,756,561.362,787,044,125.03
非流动负债合计1,074,410,314.42871,936,425.87966,649,366.68906,296,111.57
负债合计3,923,026,883.243,858,992,750.773,950,405,928.043,693,340,236.6
归属于母公司股东权益合计8,697,424,767.688,521,867,867.568,512,990,128.598,513,196,735.64
股东权益合计8,587,860,877.688,426,795,337.988,419,352,945.678,443,348,360.88
负债和股东权益合计12,510,887,760.9212,285,788,088.7512,369,758,873.7112,136,688,597.48
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计1,411,616,036.125,327,126,585.644,113,720,104.842,529,408,521.19
经营活动现金流出小计1,229,280,618.834,686,396,392.993,760,310,480.772,385,634,302.24
经营活动产生的现金流量净额182,335,417.29640,730,192.65353,409,624.07143,774,218.95
投资活动现金流入小计3,820,416799,738,546.37482,394,728.4167,195,670.97
投资活动现金流出小计111,178,114.141,344,617,424.66851,092,400.39362,661,912.89
投资活动产生的现金流量净额-107,357,698.14-544,878,878.29-368,697,671.99-195,466,241.92
筹资活动现金流入小计517,987,185.772,036,620,186.41,731,435,846.91912,169,123.01
筹资活动现金流出小计604,361,616.451,923,888,466.071,386,793,199.51704,375,974.43
筹资活动产生的现金流量净额-86,374,430.68112,731,720.33344,642,647.4207,793,148.58
汇率变动对现金及现金等价物的影响2,144,060.32-3,691,057.98-2,338,325.28-897,603.02
现金及现金等价物净增加额-9,252,651.21204,891,976.71327,016,274.2155,203,522.59
期末现金及现金等价物余额768,385,206.69777,637,857.9899,762,155.39727,949,403.78
最新报告期:2025-06-20
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
首创证券王斌0.450.620.782025-06-20
上海证券张林晚0.500.590.702025-05-07
天风证券杨松,曹文清0.600.760.912025-05-04
国盛证券张金洋,胡偌碧0.580.730.902025-05-01
华安证券谭国超0.510.590.692025-04-30
TOP↑